These growth stocks are trading at major discounts

Are these two companies cheap enough to merit purchase right now?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Many investors may be surprised to find out that there are still a number of shares trading at large discounts to their intrinsic values. That’s despite the FTSE 100 having reached a record high this year, which has pushed many stocks to higher valuations than they have achieved in recent years. However, that doesn’t mean all companies are overpriced. In fact, here are two stocks which appear to be cheap based on their future prospects. But does that mean they are worth buying today?

Impressive update

Reporting on Monday was service-led niche pharmaceutical developer, Quantum Pharma (LSE: QP). The company announced the disposal of Total Medication Management Services, which is a homecare dispensary and delivery business which trades as Biodose Services. The disposal is another significant step in the transition of the business as it seeks to focus on its core Specials and Niche Pharmaceuticals divisions. The initial cash consideration on disposal will be £1.75m, with a maximum additional contingent consideration of £0.2m.

The sale of the division improves Quantum Pharma’s EBITDA (earnings before interest, tax, depreciation and amortisation) margin by eliminating low-margin turnover. In addition, the company’s remaining divisions have traded ahead of expectations in the early months of the year. The company expects this to offset the majority of the disposed contribution from Biodose Services in the current year.

Should you invest £1,000 in Tesco right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Tesco made the list?

See the 6 stocks

Looking ahead, Quantum Pharma is expected to report a rise in its bottom line of 31% in the next financial year. Even after today’s 3%+ rise in its share price, this leaves the business trading on a price-to-earnings growth (PEG) ratio of just 0.4. This suggests its capital growth potential is high, which means it may be worth buying for the long term.

Growth potential

Also offering a wide margin of safety at the present time is sector peer Vectura (LSE: VEC). The therapeutic products and drug delivery systems specialist has a strong track record of growth. For example, in the last three years it has been able to increase its bottom line at an annualised rate of around 70%. This shows that its strategy has been working well.

Its future growth rate is also highly impressive. The company is forecast to report a rise in its bottom line of 54% next year, which could help to improve investor sentiment after a share price decline of 25% in the last year. One consequence of a disappointing year for its share price is that Vectura now trades on a PEG ratio of 0.3. This indicates that it could offer significant capital growth potential, with a margin of safety present in case there are downgrades to its forecasts.

Clearly, Vectura is a small company which may offer relatively high risks. However, with a substantial discount to its intrinsic valuation it could prove to be a sound long-term buy for less risk-averse investors.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Vectura Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Tesla building with tesla logo and two teslas in front
Investing Articles

Down 24% this year! But could Tesla stock make a stunning comeback?

Tesla stock's slumped by almost a quarter so far this year. But it's done well over the long term. So…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Is the runaway Lloyds share price about to hit a nasty bump?

Harvey Jones has been thrilled by the performance of the Lloyds share price since he bought the stock two years…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

With the FTSE 100 and S&P 500 nearing all-time highs, is it only a matter of time until a stock market crash?

Edward Sheldon's expecting some stock market volatility in the second half of 2025 given recent moves higher, but he's not…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s why I’m getting excited about the Vodafone share price!

As a long-suffering shareholder in the telecoms group, our writer explains why he’s becoming increasingly enthusiastic about the Vodafone share…

Read more »

Lady wearing a head scarf looks over pages on company financials
Investing Articles

Investors could get a second chance at this top passive income stock

Having missed an opportunity to earn 9% a year in passive income by buying Admiral shares, Stephen Wright is on…

Read more »

Fathers Walking With Their Little Boy
Investing Articles

Here’s how I could realistically turn £10,000 into a passive income worth £2,000 a month

Millions of Britons invest for a passive income. I’m no different. One day I hope to draw down on the…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Is this FTSE 100 stock at the start of a comeback?

After underperforming for some time, Rentokil shares are starting to show signs of life. Is this the start of a…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

How to target an ISA that spits out £1,000 of passive income a month

Edward Sheldon details a simple four-step plan designed to provide an investor with passive income of £12k a year or…

Read more »